speb/financial-data huggingface dataset:
CR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1332200000.00
CR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 339400000.00
CR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 50200000.00
CR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 12400000.00
CR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -247500000.00
CR cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
CR balance_sheet (annual, 2025-12-31) — Restricted Cash: 1223300000.00
CR balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 1223300000.00
CR balance_sheet (annual, 2025-12-31) — Retained Earnings: 1531500000.00
CR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1531500000.00
CR income_statement (annual, 2025-12-31) — Selling General And Administration: 548600000.00
CR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 139800000.00
CR balance_sheet (annual, 2025-12-31) — Share Issued: 57607816.00
CR balance_sheet (quarterly, 2025-12-31) — Share Issued: 57607816.00
CR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 27200000.00
CR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1800000.00
CR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2061100000.00
CR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2061100000.00
CR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1227700000.00
CR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1227700000.00
CR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CR income_statement (annual, 2025-12-31) — Tax Provision: 101100000.00
CR income_statement (quarterly, 2025-12-31) — Tax Provision: 27300000.00
CR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
CR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CR balance_sheet (annual, 2025-12-31) — Total Assets: 3853400000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Assets: 3853400000.00
CR balance_sheet (annual, 2025-12-31) — Total Capitalization: 3209300000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3209300000.00
CR balance_sheet (annual, 2025-12-31) — Total Debt: 1216200000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Debt: 1216200000.00
CR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2063400000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2063400000.00
CR income_statement (annual, 2025-12-31) — Total Expenses: 1880800000.00
CR income_statement (quarterly, 2025-12-31) — Total Expenses: 479200000.00
CR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1790000000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1790000000.00
CR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1282000000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1282000000.00
CR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1324800000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1324800000.00
CR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 424200000.00
CR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 101800000.00
CR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 6300000.00
CR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 6300000.00
CR balance_sheet (annual, 2025-12-31) — Work In Process: 106600000.00
CR balance_sheet (quarterly, 2025-12-31) — Work In Process: 106600000.00
CR balance_sheet (annual, 2025-12-31) — Working Capital: 2106200000.00
CR balance_sheet (quarterly, 2025-12-31) — Working Capital: 2106200000.00
CR income_statement (quarterly, 2026-03-31) — +Operating Expense: 181200000.00
CR income_statement (quarterly, 2026-03-31) — +Total Revenue: 696400000.00
CR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 211200000.00
CR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 493800000.00
CR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -474000000.00
CR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 451500000.00
CR balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -13000000.00
CR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 57700000.00
CR income_statement (quarterly, 2026-03-31) — Basic EPS: 1.16
CR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1729800000.00
CR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -10700000.00
CR cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -10700000.00
CR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 16700000.00
CR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 57600000.00
CR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 355400000.00
CR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 355400000.00
CR cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -14700000.00
CR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 24400000.00
CR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1366000000.00
CR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -29500000.00
CR cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: 0.00
CR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -27200000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -30100000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Inventory: -17900000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -14700000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 5500000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Payable: -27200000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -57300000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Receivables: -48800000.00
CR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -133200000.00
CR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -48800000.00
CR cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1371100000.00
CR balance_sheet (quarterly, 2026-03-31) — Common Stock: 57600000.00
CR cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -14700000.00
CR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2096900000.00
CR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 415100000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 117100000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Assets: 1481700000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 16700000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Debt: 5600000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 22300000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 59200000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 59200000.00
CR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 520200000.00
CR cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 0.00
CR cash_flow (quarterly, 2026-03-31) — Deferred Tax: 0.00
CR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 28100000.00
CR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 28100000.00
CR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 58700000.00
CR income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.14
CR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 67100000.00
CR income_statement (quarterly, 2026-03-31) — EBIT: 101900000.00
CR income_statement (quarterly, 2026-03-31) — EBITDA: 130000000.00
CR cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -3300000.00
CR balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 41700000.00
CR cash_flow (quarterly, 2026-03-31) — End Cash Position: 355400000.00
CR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 24400000.00
CR balance_sheet (quarterly, 2026-03-31) — Finished Goods: 86000000.00
CR cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -40200000.00
CR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3800000.00
CR balance_sheet (quarterly, 2026-03-31) — Goodwill: 1346400000.00
CR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2013700000.00
CR balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 506800000.00
CR balance_sheet (quarterly, 2026-03-31) — Gross PPE: 841700000.00
CR income_statement (quarterly, 2026-03-31) — Gross Profit: 281300000.00
CR cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 12500000.00
CR balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 15400000.00
CR income_statement (quarterly, 2026-03-31) — Interest Expense: 16800000.00
CR income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 16800000.00
CR income_statement (quarterly, 2026-03-31) — Interest Income: 1600000.00
CR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1600000.00
CR cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 15500000.00
CR balance_sheet (quarterly, 2026-03-31) — Inventory: 507100000.00
CR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3295100000.00
CR cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1366000000.00
CR cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 50000000.00
CR balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1192600000.00
CR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1192600000.00
CR cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 50000000.00
CR balance_sheet (quarterly, 2026-03-31) — Minority Interest: 2300000.00
CR cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -1355400000.00
CR balance_sheet (quarterly, 2026-03-31) — Net Debt: 842800000.00
CR income_statement (quarterly, 2026-03-31) — Net Income: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
CR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 67100000.00
CR cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 67100000.00
CR income_statement (quarterly, 2026-03-31) — Net Interest Income: -15200000.00
CR cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 50000000.00
CR cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 50000000.00
CR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -15200000.00
CR cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 100000.00
CR balance_sheet (quarterly, 2026-03-31) — Net PPE: 367700000.00
CR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 83200000.00
CR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 15100000.00
CR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 106000000.00
CR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 15100000.00
CR balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 106000000.00
CR balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 41700000.00
CR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 130000000.00
CR income_statement (quarterly, 2026-03-31) — Normalized Income: 67100000.00
CR cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -29500000.00
CR cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1300000.00
CR income_statement (quarterly, 2026-03-31) — Operating Income: 100100000.00
CR income_statement (quarterly, 2026-03-31) — Operating Revenue: 696400000.00
CR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 57743867.00
CR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 125400000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5600000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3800000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 100000.00
CR income_statement (quarterly, 2026-03-31) — Other Income Expense: 200000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 667300000.00
CR cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1200000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 173500000.00
CR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 92000000.00
CR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 200000.00
CR balance_sheet (quarterly, 2026-03-31) — Payables: 226600000.00
CR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 343700000.00
CR cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 1300000.00
CR balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 95000000.00
CR income_statement (quarterly, 2026-03-31) — Pretax Income: 85100000.00
CR cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -10900000.00
CR cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -1355400000.00
CR balance_sheet (quarterly, 2026-03-31) — Raw Materials: 263500000.00
CR balance_sheet (quarterly, 2026-03-31) — Receivables: 493800000.00
CR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 415100000.00
CR income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 28100000.00
CR balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 0.00
CR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1583900000.00
CR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 181200000.00
CR balance_sheet (quarterly, 2026-03-31) — Share Issued: 57743867.00
CR cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8400000.00
CR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2096900000.00
CR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 83200000.00
CR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CR income_statement (quarterly, 2026-03-31) — Tax Provision: 18000000.00
CR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
CR balance_sheet (quarterly, 2026-03-31) — Total Assets: 4051700000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3289500000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Debt: 1214900000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2099200000.00
CR income_statement (quarterly, 2026-03-31) — Total Expenses: 596300000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1952500000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2570000000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1432300000.00
CR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 100100000.00
CR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 15400000.00
CR balance_sheet (quarterly, 2026-03-31) — Work In Process: 157600000.00
CR balance_sheet (quarterly, 2026-03-31) — Working Capital: 961500000.00
CR1.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -5598.00
CR1.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 226484.00
CR1.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -5598.00
CR1.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 66868.00
CR1.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 226484.00
CR1.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 226484.00
CR1.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -5598.00
CR1.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 226484.00
CR1.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 226484.00
CR1.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -5598.00
CR1.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 66868.00
CR1.AX income_statement (annual, 2021-06-30) — Other Income Expense: 52524.00
CR1.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 52524.00
CR1.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 22622.00
CR1.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -5598.00
CR1.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1949175.00
CR1.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 26335.00
CR1.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -9433.00
CR1.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 49805052.00
CR1.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.04
CR1.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 2937105.00
CR1.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -43616.00
CR1.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 9717833.00
CR1.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 3671576.00
CR1.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 3671576.00
CR1.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 3671576.00
CR1.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 2798355.00
CR1.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -43616.00
CR1.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2020268.00
CR1.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 734471.00
CR1.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -2036419.00
CR1.AX balance_sheet (annual, 2022-06-30) — Common Stock: 9717833.00
CR1.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 4007907.00
CR1.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 2799581.00
CR1.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -1226.00
CR1.AX balance_sheet (annual, 2022-06-30) — Current Assets: 3689672.00
CR1.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 77590.00
CR1.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 18765.00
CR1.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 3121.00
CR1.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 3121.00
CR1.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 3121.00
CR1.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 49805052.00
CR1.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.04
CR1.AX income_statement (annual, 2022-06-30) — EBIT: -1949175.00
CR1.AX income_statement (annual, 2022-06-30) — EBITDA: -1946054.00
CR1.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3671576.00
CR1.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 2798355.00
CR1.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -2063884.00
CR1.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 1342605.00
CR1.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 535650.00
CR1.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 405258.00
CR1.AX income_statement (annual, 2022-06-30) — Interest Income: 16151.00
CR1.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 16151.00
CR1.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 16151.00
CR1.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 4007907.00
CR1.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -43616.00
CR1.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 2799581.00
CR1.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 55258.00
CR1.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 2798355.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Net Interest Income: 16151.00
CR1.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 16151.00
CR1.AX balance_sheet (annual, 2022-06-30) — Net PPE: 395825.00
CR1.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -43616.00
CR1.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 4007907.00
CR1.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -1946054.00
CR1.AX income_statement (annual, 2022-06-30) — Normalized Income: -1929903.00
CR1.AX income_statement (annual, 2022-06-30) — Operating Income: -1949175.00
CR1.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 50883963.00
CR1.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 1342605.00
CR1.AX income_statement (annual, 2022-06-30) — Other Gand A: 517332.00
CR1.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 1410404.00
CR1.AX balance_sheet (annual, 2022-06-30) — Other Payable: 32490.00
CR1.AX balance_sheet (annual, 2022-06-30) — Other Properties: 350000.00
CR1.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 18096.00
CR1.AX balance_sheet (annual, 2022-06-30) — Payables: 58825.00
CR1.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 58825.00
CR1.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -2036419.00
CR1.AX income_statement (annual, 2022-06-30) — Pretax Income: -1929903.00
CR1.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -43616.00
CR1.AX balance_sheet (annual, 2022-06-30) — Receivables: 18096.00
CR1.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 3121.00
CR1.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -1226.00
CR1.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -7052531.00
CR1.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 18318.00
CR1.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 535650.00
CR1.AX balance_sheet (annual, 2022-06-30) — Share Issued: 50883963.00
CR1.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 4007907.00
CR1.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 4007907.00
CR1.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
CR1.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
CR1.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Assets: 4085497.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 4007907.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 4007907.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 77590.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 395825.00
CR1.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CR1.AX balance_sheet (annual, 2022-06-30) — Working Capital: 3612082.00
CR1.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1354234.00
CR1.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 21017.00
CR1.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -20167.00
CR1.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 50883963.00
CR1.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.03
CR1.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3671576.00
CR1.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 9717833.00
CR1.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 2415108.00
CR1.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 2415108.00
CR1.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 2415108.00
CR1.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1256468.00
CR1.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -1256468.00
CR1.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1326816.00
CR1.AX balance_sheet (annual, 2023-06-30) — Common Stock: 9717833.00
CR1.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 2735727.00
CR1.AX balance_sheet (annual, 2023-06-30) — Current Assets: 2415544.00
CR1.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 64908.00
CR1.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 15528.00
CR1.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 10734.00
CR1.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 10734.00
CR1.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 10734.00
CR1.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 50883963.00
CR1.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.03
CR1.AX income_statement (annual, 2023-06-30) — EBIT: -1354234.00
CR1.AX income_statement (annual, 2023-06-30) — EBITDA: -1343500.00
CR1.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2415108.00
CR1.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -1256468.00
CR1.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 1200148.00
CR1.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 425572.00
CR1.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 405258.00
CR1.AX income_statement (annual, 2023-06-30) — Interest Income: 70348.00
CR1.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 70348.00
CR1.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 70348.00
CR1.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 2735727.00
CR1.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 55258.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Net Interest Income: 70348.00
CR1.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 70348.00
CR1.AX balance_sheet (annual, 2023-06-30) — Net PPE: 385091.00
CR1.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 2735727.00
CR1.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1343500.00
CR1.AX income_statement (annual, 2023-06-30) — Normalized Income: -1273152.00
CR1.AX income_statement (annual, 2023-06-30) — Operating Income: -1354234.00
CR1.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 50883963.00
CR1.AX cash_flow (annual, 2023-06-30) — Other Cash Paymentsfrom Operating Activities: -737322.00
CR1.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 1200148.00
CR1.AX income_statement (annual, 2023-06-30) — Other Gand A: 424600.00
CR1.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 917928.00
CR1.AX balance_sheet (annual, 2023-06-30) — Other Payable: 28363.00
CR1.AX balance_sheet (annual, 2023-06-30) — Other Properties: 350000.00
CR1.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 436.00
CR1.AX balance_sheet (annual, 2023-06-30) — Payables: 49380.00
CR1.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 49380.00
CR1.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -589494.00
CR1.AX income_statement (annual, 2023-06-30) — Pretax Income: -1273152.00
CR1.AX balance_sheet (annual, 2023-06-30) — Receivables: 436.00
CR1.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 10734.00
CR1.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -8182254.00
CR1.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 972.00
CR1.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 425572.00
CR1.AX balance_sheet (annual, 2023-06-30) — Share Issued: 50883963.00
CR1.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 2735727.00
CR1.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 2735727.00
CR1.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
CR1.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
CR1.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Assets: 2800635.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 2735727.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 2735727.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 64908.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 385091.00
CR1.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CR1.AX balance_sheet (annual, 2023-06-30) — Working Capital: 2350636.00
CR1.AX income_statement (annual, 2024-06-30) — +Operating Expense: 1984873.00
CR1.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 47029.00
CR1.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -25214.00
CR1.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 53373901.00
CR1.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.04
CR1.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 2415108.00
CR1.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -3490.00
CR1.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 11074386.00
CR1.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 2293234.00
CR1.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 2293234.00
CR1.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 2293234.00
CR1.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 1356553.00
CR1.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -3490.00
CR1.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1474937.00
CR1.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -121874.00
CR1.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -1557698.00
CR1.AX balance_sheet (annual, 2024-06-30) — Common Stock: 11074386.00
CR1.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 2580035.00
CR1.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 1393000.00
CR1.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -36447.00
CR1.AX balance_sheet (annual, 2024-06-30) — Current Assets: 2302032.00
CR1.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 101286.00
CR1.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 20646.00
CR1.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 9292.00
CR1.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 9292.00
CR1.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 9292.00
CR1.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 53373901.00
CR1.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.04
CR1.AX income_statement (annual, 2024-06-30) — EBIT: -1984873.00
CR1.AX income_statement (annual, 2024-06-30) — EBITDA: -1975581.00
CR1.AX cash_flow (annual, 2024-06-30) — End Cash Position: 2293234.00
CR1.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 1356553.00
CR1.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -1478427.00
CR1.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1580822.00
CR1.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 816249.00
CR1.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 404503.00
CR1.AX income_statement (annual, 2024-06-30) — Interest Income: 82662.00
CR1.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 82662.00
CR1.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 82761.00
CR1.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 2580035.00
CR1.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -3490.00
CR1.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 1393000.00
CR1.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 54503.00
CR1.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 1356553.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Net Interest Income: 82662.00
CR1.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 82662.00
CR1.AX balance_sheet (annual, 2024-06-30) — Net PPE: 379289.00
CR1.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -3490.00
CR1.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 2580035.00
CR1.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -1975581.00
CR1.AX income_statement (annual, 2024-06-30) — Normalized Income: -1892919.00
CR1.AX income_statement (annual, 2024-06-30) — Operating Income: -1984873.00
CR1.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 62719912.00
CR1.AX cash_flow (annual, 2024-06-30) — Other Cash Paymentsfrom Operating Activities: -835085.00
CR1.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 1580822.00
CR1.AX income_statement (annual, 2024-06-30) — Other Gand A: 435575.00
CR1.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 1159332.00
CR1.AX balance_sheet (annual, 2024-06-30) — Other Payable: 33611.00
CR1.AX balance_sheet (annual, 2024-06-30) — Other Properties: 350000.00
CR1.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 8798.00
CR1.AX balance_sheet (annual, 2024-06-30) — Payables: 80640.00
CR1.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 80640.00
CR1.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -722613.00
CR1.AX income_statement (annual, 2024-06-30) — Pretax Income: -1892919.00
CR1.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -3490.00
CR1.AX balance_sheet (annual, 2024-06-30) — Receivables: 8798.00
CR1.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 9292.00
CR1.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -36447.00
CR1.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -10075173.00
CR1.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 380674.00
CR1.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 816249.00
CR1.AX balance_sheet (annual, 2024-06-30) — Share Issued: 62719912.00
CR1.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 2580035.00
CR1.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 2580035.00
CR1.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
CR1.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
CR1.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Assets: 2681321.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 2580035.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 2580035.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 101286.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 379289.00
CR1.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CR1.AX balance_sheet (annual, 2024-06-30) — Working Capital: 2200746.00
CR1.AX income_statement (annual, 2025-06-30) — +Operating Expense: 3034951.00
CR1.AX balance_sheet (annual, 2025-06-30) — Accounts Payable: 256108.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 256108.00
CR1.AX balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -35987.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -35987.00
CR1.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 62642186.00
CR1.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.05
CR1.AX cash_flow (annual, 2025-06-30) — Beginning Cash Position: 2293234.00
CR1.AX cash_flow (annual, 2025-06-30) — Capital Expenditure: -39762.00
CR1.AX cash_flow (annual, 2025-06-30) — Capital Expenditure Reported: -25733.00
CR1.AX balance_sheet (annual, 2025-06-30) — Capital Stock: 11306970.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 11306970.00
CR1.AX balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 330901.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 330901.00
CR1.AX balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 330901.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 330901.00
CR1.AX balance_sheet (annual, 2025-06-30) — Cash Financial: 330901.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 330901.00
CR1.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: 157245.00
CR1.AX cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: -39762.00
CR1.AX cash_flow (annual, 2025-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2079816.00
CR1.AX cash_flow (annual, 2025-06-30) — Changes In Cash: -1962333.00
CR1.AX cash_flow (annual, 2025-06-30) — Classesof Cash Payments: -2134552.00
CR1.AX balance_sheet (annual, 2025-06-30) — Common Stock: 11306970.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 11306970.00
CR1.AX balance_sheet (annual, 2025-06-30) — Common Stock Equity: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 197562.00
CR1.AX cash_flow (annual, 2025-06-30) — Common Stock Payments: -2755.00
CR1.AX balance_sheet (annual, 2025-06-30) — Current Assets: 398190.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 398190.00
CR1.AX balance_sheet (annual, 2025-06-30) — Current Liabilities: 494245.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 494245.00
CR1.AX balance_sheet (annual, 2025-06-30) — Current Provisions: 46937.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Current Provisions: 46937.00
CR1.AX income_statement (annual, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 10773.00
CR1.AX income_statement (annual, 2025-06-30) — Depreciation And Amortization In Income Statement: 10773.00
CR1.AX income_statement (annual, 2025-06-30) — Depreciation Income Statement: 10773.00
CR1.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 62642186.00
CR1.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.05
CR1.AX income_statement (annual, 2025-06-30) — EBIT: -3034951.00
CR1.AX income_statement (annual, 2025-06-30) — EBITDA: -3024178.00
CR1.AX cash_flow (annual, 2025-06-30) — End Cash Position: 330901.00
CR1.AX cash_flow (annual, 2025-06-30) — Financing Cash Flow: 157245.00
CR1.AX cash_flow (annual, 2025-06-30) — Free Cash Flow: -2119578.00
CR1.AX balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1935323.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1935323.00
CR1.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 810392.00
CR1.AX balance_sheet (annual, 2025-06-30) — Gross PPE: 329604.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 329604.00
CR1.AX income_statement (annual, 2025-06-30) — Interest Income: 54620.00
CR1.AX income_statement (annual, 2025-06-30) — Interest Income Non Operating: 54620.00
CR1.AX cash_flow (annual, 2025-06-30) — Interest Received Direct: 54736.00
CR1.AX balance_sheet (annual, 2025-06-30) — Invested Capital: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 197562.00
CR1.AX cash_flow (annual, 2025-06-30) — Investing Cash Flow: -39762.00
CR1.AX balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 68532.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 68532.00
CR1.AX cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: -2755.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Net Interest Income: 54620.00
CR1.AX income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 54620.00
CR1.AX cash_flow (annual, 2025-06-30) — Net Other Financing Charges: 160000.00
CR1.AX balance_sheet (annual, 2025-06-30) — Net PPE: 293617.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 293617.00
CR1.AX cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -14029.00
CR1.AX balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 197562.00
CR1.AX income_statement (annual, 2025-06-30) — Normalized EBITDA: -3024178.00
CR1.AX income_statement (annual, 2025-06-30) — Normalized Income: -2969558.00
CR1.AX income_statement (annual, 2025-06-30) — Operating Income: -3034951.00
CR1.AX balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 63039225.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 63039225.00
CR1.AX cash_flow (annual, 2025-06-30) — Other Cash Paymentsfrom Operating Activities: -1667203.00
CR1.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 1935323.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1935323.00
CR1.AX income_statement (annual, 2025-06-30) — Other Gand A: 455891.00
CR1.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 2213786.00
CR1.AX balance_sheet (annual, 2025-06-30) — Other Payable: 191200.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 191200.00
CR1.AX balance_sheet (annual, 2025-06-30) — Other Properties: 261072.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Other Properties: 261072.00
CR1.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 48328.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 48328.00
CR1.AX balance_sheet (annual, 2025-06-30) — Payables: 447308.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Payables: 447308.00
CR1.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 447308.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 447308.00
CR1.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -467349.00
CR1.AX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 18961.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 18961.00
CR1.AX income_statement (annual, 2025-06-30) — Pretax Income: -2969558.00
CR1.AX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -14029.00
CR1.AX balance_sheet (annual, 2025-06-30) — Receivables: 48328.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 48328.00
CR1.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 10773.00
CR1.AX cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -2755.00
CR1.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: -13044731.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -13044731.00
CR1.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 354501.00
CR1.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 810392.00
CR1.AX balance_sheet (annual, 2025-06-30) — Share Issued: 63039225.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 63039225.00
CR1.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 197562.00
CR1.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 197562.00
CR1.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CR1.AX income_statement (annual, 2025-06-30) — Tax Provision: 0.00
CR1.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Assets: 691807.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 691807.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 197562.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 197562.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 197562.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 494245.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 494245.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 293617.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 293617.00
CR1.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CR1.AX balance_sheet (annual, 2025-06-30) — Working Capital: -96055.00
CR1.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: -96055.00
CR3.AX income_statement (annual, 2021-06-30) — +Operating Expense: 1860126.00
CR3.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 594665.00
CR3.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -23854.00
CR3.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 79265819.00
CR3.AX income_statement (annual, 2021-06-30) — Basic EPS: -0.02
CR3.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 1344249.00
CR3.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -1524739.00
CR3.AX cash_flow (annual, 2021-06-30) — Capital Expenditure Reported: -1519933.00
CR3.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 8832.00
CR3.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 10551004.00